Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling

被引:79
作者
Geha, RM
Chen, K
Wouters, J
Ooms, F
Shih, JC
机构
[1] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA
[3] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium
关键词
D O I
10.1074/jbc.M110920200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidase (MAO) is a key enzyme responsible for the degradation of serotonin, norepinephrine, dopamine, and phenylethylamine. It is an outer membrane mitochondrial enzyme existing in two isoforms, A and B. We have recently generated 14 site-directed mutants of human MAO A and B, and we found that four key amino acids, Lys-305, Trp-397, Tyr-407, and Tyr-444, in MAO A and their corresponding amino acids in MAO B, Lys-296, Trp-388, Tyr-398, and Tyr-435, play important roles in MAO catalytic activity. Based on the polyamine oxidase three-dimensional crystal structure, it is suggested that Lys-305, Trp-397, and Tyr-407 in MAO A and Lys-296, Trp-388, and Tyr-398 in MAO B may be involved in the non-covalent binding to FAD. Tyr-407 and Tyr-444 in MAO A (Tyr-398 and Tyr-435 in MAO B) may form an aromatic sandwich that stabilizes the substrate binding. Asp-132 in MAO A (Asp-123 in MAO B) located at the entrance of the U-shaped substrate-binding site has no effect on MAO A nor MAO B catalytic activity. The similar impact of analogous mutants in MAO A and MAO B suggests that these amino acids have the same function in both isoenzymes. Three-dimensional modeling of MAO A and B using polyamine oxidase as template suggests that the overall tertiary structure and the active sites of MAO A and B may be similar.
引用
收藏
页码:17209 / 17216
页数:8
相关论文
共 45 条
  • [1] BACK AJW, 1988, P NATL ACAD SCI USA, V85, P4934
  • [2] A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase
    Binda, C
    Coda, A
    Angelini, R
    Federico, R
    Ascenzi, P
    Mattevi, A
    [J]. STRUCTURE, 1999, 7 (03) : 265 - 276
  • [3] Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
    Binda, C
    Newton-Vinson, P
    Hubálek, F
    Edmondson, DE
    Mattevi, A
    [J]. NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) : 22 - 26
  • [4] Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis
    Cesura, AM
    Gottowik, J
    Lahm, HW
    Lang, G
    Imhof, R
    Malherbe, P
    Rothlisberger, U
    DaPrada, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (03): : 996 - 1002
  • [5] CHEN K, 1994, MOL PHARMACOL, V46, P1226
  • [6] METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE
    CHIBA, K
    TREVOR, A
    CASTAGNOLI, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) : 574 - 578
  • [7] Identification of an FAD superfamily containing protoporphyrinogen oxidases, monoamine oxidases, and phytoene desaturase -: Expression and characterization of phytoene desaturase of Myxococcus xanthus
    Dailey, TA
    Dailey, HA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13658 - 13662
  • [8] Structure and function prediction of the Brucella abortus P39 protein by comparative modeling with marginal sequence similarities
    de Fays, K
    Tibor, A
    Lambert, C
    Vinals, C
    Denoël, P
    De Bolle, X
    Wouters, J
    Letesson, JJ
    Depiereux, E
    [J]. PROTEIN ENGINEERING, 1999, 12 (03): : 217 - 223
  • [9] Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway
    De Zutter, GS
    Davis, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 6168 - 6173
  • [10] Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249